₹836.30 33.10 (4.12%)
04:01 PM, 24-Dec-2025₹816.40 11.90 (1.48%)
03:48 PM, 24-Dec-2025BSE : 544319
NSE : SENORES
Sector : Health care
ISIN Code : INE0RB801010
Last Updated: 24-Dec-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 3,851 |
Traded Value (₹ Cr) | 69.23 |
Volume (Shares) | 8,27,862 |
Face Value (₹) | 10 |
52-Week High (₹) | 847.90 |
52-Week High Date | 15-Dec-2025 |
52-Week Low (₹) | 440.00 |
52-Week Low Date | 13-Jan-2025 |
All Time High (₹) | 847.90 |
All Time High Date | 15-Dec-2025 |
All Time Low (₹) | 440.00 |
All Time Low Date | 13-Jan-2025 |
Senores Pharmaceuticals Limited has informed the Exchange regarding granting of Inter Corporate Loan
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 3,760 |
| EPS - TTM (₹) [C] | 18.61 |
| P/E Ratio (X) [C] | 43.87 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 176.75 |
| P/B Ratio (₹) [C] | 4.62 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| ICICI Pru P.H.D Fund (G) | 52.79 | 6,40,883 | 0.82 |
| ICICI Pru P.H.D Fund (IDCW) | 52.79 | 6,40,883 | 0.82 |
| ICICI Pru P.H.D Fund - Direct (G) | 52.79 | 6,40,883 | 0.82 |
| ICICI Pru P.H.D Fund - Direct (IDCW) | 52.79 | 6,40,883 | 0.82 |
| Mahindra Manulife Large & Mid Cap Fund-Reg (G) | 52.64 | 6,39,101 | 1.88 |
| Mahindra Manulife Large & Mid Cap Fund-Reg (IDCW) | 52.64 | 6,39,101 | 1.88 |
| Mahindra Manulife Large & Mid Cap Fund-Dir (G) | 52.64 | 6,39,101 | 1.88 |
| Mahindra Manulife Large & Mid Cap Fund-Dir (IDCW) | 52.64 | 6,39,101 | 1.88 |
| Mahindra Manulife Balanced Advantage Fund (G) | 8.81 | 1,07,000 | 0.94 |
| Mahindra Manulife Balanced Advantage Fund (IDCW) | 8.81 | 1,07,000 | 0.94 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
| Today's Low/High (₹) | 792.00 839.00 |
| Week Low/High (₹) | 779.05 839.00 |
| Month Low/High (₹) | 738.10 849.00 |
| Year Low/High (₹) | 435.25 849.00 |
| All time Low/High (₹) | 440.00 849.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 2.15% | 2.19% | 1.00% | 1.25% |
| 1 Month | 2.80% | 2.84% | 0.60% | 0.70% |
| 3 Month | 16.16% | 16.11% | 4.52% | 4.33% |
| 6 Month | 53.92% | 53.79% | 4.09% | 4.38% |
| 1 Year | - | - | 8.84% | 10.18% |
| 3 Year | - | - | 42.72% | 46.81% |
Managing Director : SWAPNIL JATINBHAI SHAH
Chairman (Non-Executive) : Sanjay Majmudar
Non Executive Director : Hemanshu Nitinchandra Pandya
Independent Director : Jitendra Babulal Sanghvi
Whole Time Director & Chief Operating Officer : Chetan Bipinchandra Shah
Whole Time Director & Chief Financial Officer : Deval Rajnikant Shah
Non Executive Director : Ashokkumar Vijaysinh Barot
Non Executive Director : ARPIT DEEPAKKUMAR SHAH
Independent Director : Naresh Bansilal Shah
Independent Director : Manjula Devi Shroff
Independent Director : Kalpit Rajesh Gandhi
Independent Director : Udayan Choksi
Company Sec. & Compli. Officer : Nidhi Dilipbhai Kapadia
Registered Office: #.1101-1103 11th Flr South Twr, Ambali Bopal Road,Ahmedabad,Gujarat-380054 Ph: +91-79-2999 9857
Email:cs@senorespharma.com
1. What's the Senores Pharmaceuticals Ltd share price today?
Senores Pharmaceuticals Ltd share price was Rs 836.30 at 04:01 PM IST on 24th Dec 2025. Senores Pharmaceuticals Ltd share price was up by 4.12% over the previous closing price of Rs 803.20. Senores Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Senores Pharmaceuticals Ltd stock?
The performance of the Senores Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd has a market capitalisation of Rs 3,851 crore.
4. What is Senores Pharmaceuticals Ltd's 52-week high/low share price?
The Senores Pharmaceuticals Ltd’s 52-week high share price is Rs 847.90 and 52-week low share price is Rs 440.00.
5. Is the Senores Pharmaceuticals Ltd profitable?
On a consolidated basis, Senores Pharmaceuticals Ltd reported a profit of Rs 30.12 crore on a total income of Rs 167.17 crore for the quarter ended 2025.
6. Which are Senores Pharmaceuticals Ltd’s peers in the Health care sector?
Senores Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Orchid Pharma, RPG LifeScience., Aarti Drugs, Senores Pharma., Advanced Enzyme, Gufic BioScience, Unichem Labs..
7. Who owns how much in Senores Pharmaceuticals Ltd?
Key changes to the Senores Pharmaceuticals Ltd shareholding are as follows: